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Autism spectrum disorders (ASD) are characterized by a high degree of genetic
heterogeneity. Genomic studies identified common pathological processes underlying
the heterogeneous clinical manifestations of ASD, and transcriptome analyses
revealed that gene networks involved in synapse development, neuronal activity, and
immune function are deregulated in ASD. Mouse models provide unique tools to
investigate the neurobiological basis of ASD; however, a comprehensive approach
to identify transcriptional abnormalities in different ASD models has never been
performed. Here we used two well-recognized ASD mouse models, BTBR T+
Itpr3tf /J (BTBR) and Engrailed-2 knockout (En2−/−), to identify conserved ASD-related
molecular signatures. En2−/− mice bear a mutation within the EN2 transcription
factor homeobox, while BTBR is an inbred strain with unknown genetic defects.
Hippocampal RNA samples from BTBR, En2−/− and respective control (C57Bl/6J
and En2+/+) adult mice were assessed for differential gene expression using
microarrays. A total of 153 genes were similarly deregulated in the BTBR and
En2−/− hippocampus. Mouse phenotype and gene ontology enrichment analyses
were performed on BTBR and En2−/− hippocampal differentially expressed genes
(DEGs). Pathways represented in both BTBR and En2−/− hippocampal DEGs
included abnormal behavioral response and chemokine/MAP kinase signaling. Genes
involved in abnormal function of the immune system and abnormal synaptic
transmission/seizures were significantly represented among BTBR and En2−/− DEGs,
respectively. Interestingly, both BTBR and En2−/− hippocampal DEGs showed a
significant enrichment of ASD and schizophrenia (SCZ)-associated genes. Specific
gene sets were enriched in the two models: microglial genes were significantly
enriched among BTBR DEGs, whereas GABAergic/glutamatergic postsynaptic genes,
FMRP-interacting genes and epilepsy-related genes were significantly enriched among
En2−/− DEGs. Weighted correlation network analysis (WGCNA) performed on BTBR
and En2−/− hippocampal transcriptomes together identified six modules significantly
enriched in ASD-related genes. Each of these modules showed a specific enrichment
profile in neuronal and glial genes, as well as in genes associated to ASD comorbidities
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such as epilepsy and SCZ. Our data reveal significant transcriptional similarities and
differences between the BTBR and En2−/− hippocampus, indicating that transcriptome
analysis of ASD mouse models may contribute to identify novel molecular targets for
pharmacological studies.
Keywords: autism, hippocampus, gene expression, microarray, WGCNA, BTBR, Engrailed, mouse
INTRODUCTION
Autism spectrum disorders (ASD) are a family of
neurodevelopmental disorders characterized by a high degree of
genetic heterogeneity. Recent advances in genetics and genomics
allowed to attribute the heterogeneous clinical manifestations of
ASD to shared pathophysiological processes (de la Torre-Ubieta
et al., 2016). Integrative analysis of large-scale genetic data
revealed distinct gene networks affected in ASD, mainly related
to the formation and function of brain synapses. Network-based
analysis of large-scale transcriptome data also highlighted that
co-expressionmodules related to synapse development, neuronal
activity and immune function are deregulated in ASD (Voineagu
et al., 2011; Gupta et al., 2014; de la Torre-Ubieta et al., 2016).
Thus, pathophysiological processes in ASD seem to converge on
specific molecular pathways and networks, with a clear interplay
between immune and synaptic functions (Estes and McAllister,
2015).
Gene transcriptional profiling in ASD is mainly performed
on post-mortem brain samples, but the restricted availability
of human ASD brain tissues represents a significant challenge.
For this reason, ASD mouse models provide a unique tool
to identify conserved pathological mechanisms at the gene
expression level. BTBR T+ Itpr3tf /J (BTBR) is an inbred strain
of mice that incorporates behavioral phenotypes relevant to
all diagnostic symptoms of ASD, including reduced social
interactions in juveniles and adults, repetitive self-grooming and
an unusual pattern of ultrasonic vocalizations resembling the
atypical vocalizations seen in some autistic children (Scattoni
et al., 2008, 2013). Moreover, BTBRmice show a severely reduced
hippocampal commissure and absent corpus callosum (Wahlsten
et al., 2003). Noteworthy, corpus callosum abnormalities have
been reported in autistic individuals (Egaas et al., 1995; Alexander
et al., 2007). However, it is important to emphasize that genetic
abnormalities causing behavioral deficits in BTBR mice are still
under investigation (Jones-Davis et al., 2013).
Engrailed-2 (EN2) is a homeodomain transcription factor
involved in regionalization and patterning of the midbrain
and hindbrain regions (Joyner et al., 1991). Genome-wide
association studies revealed that EN2 is a candidate gene for
ASD (Benayed et al., 2009), and an abnormal expression and
methylation profile of the EN2 gene has been reported in
the cerebellum of ASD patients (James et al., 2013, 2014;
Choi et al., 2014). Mice lacking the homeobox domain of
En2 (En2hd/hd mice; Joyner et al., 1991; here referred to as
En2−/−) display neuropathological changes related to ASD.
These defects include cerebellar hypoplasia and reduced number
of Purkinje neurons (Joyner et al., 1991; Kuemerle et al., 1997),
defective GABAergic innervation in the forebrain (Sgadò et al.,
2013a; Allegra et al., 2014; Provenzano et al., 2014), reduced
monoaminergic innervation to the forebrain (Brielmaier et al.,
2014; Genestine et al., 2015; Viaggi et al., 2015) and ASD-like
behavioral traits such as decreased sociability, spatial learning
deficits, and increased seizure susceptibility (Cheh et al., 2006;
Tripathi et al., 2009; Brielmaier et al., 2012; Provenzano et al.,
2014).
So far, a comprehensive approach to identify common and
distinct abnormalities in ASD models has been conducted by
brain imaging-based neuroanatomical phenotyping (Ellegood
et al., 2015; Ellegood and Crawley, 2015). However, few efforts
have been made to identify conserved genes signatures at
the transcriptome level in brain tissues from ASD mice. The
hippocampal and cortical transcriptome has been examined
in BTBR mice (Daimon et al., 2015; Kratsman et al., 2016),
while we evaluated the gene expression signature of the En2−/−
hippocampus and cerebellum (Sgadò et al., 2013b). Similar
studies have been performed on brains from Fmr1 (Prilutsky
et al., 2015) and Pten (Tilot et al., 2016) mutant mice.
However, a comprehensive approach to identify transcriptional
abnormalities in ASD mouse models has never been performed
so far. Here we compared the transcriptome profile of the
BTBR and En2−/− hippocampus, and describe common and
distinct transcriptional signatures for these two ASD mouse
models.
MATERIALS AND METHODS
Animals
Experiments were conducted in conformity with the European
Community Directive 2010/63/EU and were approved by the
Animal Welfare Committee of University of Trento, Istituto
Superiore di Sanità and Italian Ministry of Health. Animals
were housed in a 12 h light/dark cycle with food and water
available ad libitum, and all efforts weremade tominimize animal
suffering during the experiments. En2 mutants were originally
generated on a mixed 129Sv x C57BL/6 genetic background
(Joyner et al., 1991) and then backcrossed at least five times
into a C57BL/6 background. En2+/+ and En2−/− mice used
in this study were obtained by heterozygous mating (En2+/− x
En2+/−) and genotyped by PCR as previously described (Sgadò
et al., 2013a). BTBR T+ Itpr3tf /J (BTBR) and C57Bl/6J (B6)
inbred mice were purchased from the Jackson Laboratory (Bar
Harbour, ME, USA) and bred in the mouse vivarium of the
Istituto Superiore di Sanità (Rome, Italy). A total of 32 adult
(3–5 months old) mice were used: 4 BTBR and 4 B6 mice for
microarray experiments, and 6 mice per strain/genotype (BTBR,
B6, En2+/+ and En2−/−) for quantitative RT-PCR.
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Microarrays and Single-Gene Differential
Expression Analysis
In this study, we aimed to identify common and distinct
molecular signatures across the hippocampi of BTBR and
En2−/− mice. To obtain a comparable and reliable hippocampal
transcriptomic profile of BTBR mice and reduce any source
of variability during microarray analysis, which might arise
from pre-scanning and/or post-scanning steps (Kadanga et al.,
2008), we applied the same experimental procedures previously
described for the transcriptome analysis of En2−/− hippocampus
(Sgadò et al., 2013b). Briefly, hippocampal RNAs from BTBR and
B6 mice (n = 4 per experimental group) were purified using
standard column purification according to the manufacturer’s
protocol (RNAeasy Mini Kit, QIAGEN). RNA quality was
analyzed by microfluidic gel electrophoresis on RNA 6000
NanoChips using the Agilent 2100 Bioanalyzer. Only RNA
with a high (>9) RNA integrity number was selected and
used for subsequent retrotranscription, labeling, and array
hybridization according to Agilent protocols. Mouse gene
expression arrays (Agilent 4X44K slides) were hybridized and
scanned with the Agilent microarray station. The images
obtained from the microarray scanner were analyzed with
Agilent Feature Extraction version 10.7.3.1. Hippocampal gene
expression dataset of BTBR and B6 mice have been deposited
in the NCBI’s Gene Expression Omnibus (GEO) database
(accession number GSE81501). Intensity values were processed
with Agi4x44PreProcess using default parameters to remove
low-quality probes. Signals were then normalized by means of
the quantile normalization method. Multiple replicas of the
same probes were summarized using the median. To evaluate
differential expression, the Rank Product (RP) non-parametric
method was used (Sgadò et al., 2013b). The RP is equivalent to
calculating the geometric mean rank with a statistical method
(average rank) that is slightly more sensitive to outlier data and
puts a higher premium on consistency between the ranks in
various lists.
Quantitative RT-PCR (qRT-PCR)
Total RNAs were extracted by Trizol reagent (Invitrogen) from
explanted hippocampi. DNase-treated RNAs were purified by
RNA extraction RNAeasy Kit (QIAGEN). cDNA was synthesized
from pooled RNAs by SuperScript VILO cDNA Synthesis
Kit (Invitrogen) according to the manufacturer’ instructions.
qRT-PCR was performed in a C1000 Thermal Cycler (Bio-
Rad) with real-time detection of fluorescence, using the KAPA
SYBR FAST Master Mix reagent (KAPA Biosystems). Mouse
mitochondrial ribosomal protein L41 (mRPL41) was used
as a standard for quantification. Primer sequences (Eurofins
Genomics) are reported in Supplementary Table 1. Ratios of
comparative concentrations of each mRNA with respect to
L41 mRNA were then calculated and plotted as the average
of three independent reactions (technical replicates) obtained
from each RNA. Expression analyses were performed using
the CFX3 Manager (Bio-Rad) software (Sgadò et al., 2013b).
Statistical analysis of qRT-PCR was performed with Prism 6
(GraphPad) software. Values were expressed as mean± s.e.m and
quantitative gene expression differences between each autistic
mouse (BTBR and En2−/−) strain and their respective controls
(B6 and En2+/+) were assessed by Student’s t-test, with the level
of statistical significance set at p < 0.05.
Phenotype/Pathway Ontology and
Enrichment Analysis on DEGs
DEGs in BTBR and En2−/− hippocampi were analyzed
for “phenotype ontology” using Enrichr (http://amp.pharm.
mssm.edu/Enrichr/). Enrichr is an enrichment analysis web-
based tool providing various types of gene-set libraries,
including the knockout mouse phenotypes ontology developed
by the Jackson Lab from their Mouse Genome Informatics-
Mammalian Phenotype (MGI-MP) browser (Blake et al., 2009).
Mammalian phenotypes predefined byMGI are sorted by z-score
considering only terms with an adjusted p-value less than 0.05.
Phenotype/pathway ontology of En2−/− hippocampal DEGs was
performed on our previous dataset from En2+/+ and En2−/−
adult mice, already deposited in NCBI’s GEO database (accession
number GSE51612; Sgadò et al., 2013b). In order to visualize
enriched Kyoto Encyclopedia of Genes and Genomes (KEGG)
pathways, we used DAVID v6.7 (http://david.abcc.ncifcrf.gov/).
To focus the functional analysis on hippocampal expressed genes
we used as background a list of tissue-specific expressed genes for
both autistic (BTBR and En2−/−) strains. These background lists
were obtained by filtering the genes by the normalized expression
values and excluding the ones with the lowest expression levels
(<10th percentile).
We also performed the direct enrichment analysis of different
gene set categories present in the DEGs from BTBR and En2−/−
mice, using the hypergeometric test present in R (P-value cut-off
0.05). The background used to compute the enrichments was the
same used for KEGG pathway analysis (see below for the gene
lists used for enrichment analyses).
Weighted Correlation Network Analysis
(WGCNA) and Enrichment on
Co-expression Modules
Microarray data from the BTBR and En2−/− hippocampi
were analyzed with the WGCNA R package in order to find
highly correlated modules of co-expressed genes (Langfelder and
Horvath, 2008). Two different batches of samples, autistic (BTBR
and En2−/−) vs. control (B6 and En2+/+), were used to obtain
an appropriate number for the WGCNA analysis. All samples
were normalized and filtered using the same method described
above. The R program ComBat (Johnson et al., 2007) included
in the SVA package (Leek et al., 2012) was used to remove the
batch effect present on different chips, in which samples were
run. In order to keep the most informative probes, only the top
20% (in terms of per-probe variance) were used as input for
the WGCNA analysis. The WGCNA method is based on soft
threshold approach in order to obtain an adjacency matrix that
describes the relations among the genes (Zhang and Horvath,
2005). The scale-free criterion is used to select the power to apply
to the correlations in order to obtain the adjacency matrix, a
power of 11 was chosen in this study. The Topological Overlap
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Measure (TOM) is then calculated starting from the previously
obtained adjacency matrix. TOM is a highly robust measure
of network interconnectedness (proximity) and expresses the
strength characterizing the connection between each pair of
genes. Genes with high TOM are clustered into co-expression
modules. kME (representing the connection strength of each
gene in each module) is then calculated as the correlation of each
gene to the module eigengene (ME, defined as the first principal
component of the expressions of the genes within the module).
The ME defines measures of module membership (MM), which
quantify how close a gene is to a given module eigengene. For
each expression profile, Gene Significance (GS) was calculated as
the absolute value of the correlation between expression profile
and trait (autistic phenotype). The statistical significance of MM
and GS (denoted as p.MM and p.GS) is carried out from the
correlation test p-value of the WGCNA package. All values are
tabulated in Supplementary Table 3. Given autism is a complex
and very heterogeneous group of disorders, simple correlation
of the modules with the trait produced meaningless results. A
different approach was hence used: the modules were ranked
based on their enrichment in term of genes present in the SFARI
list. Then, modules significantly enriched in ASD-associated
genes were functionally characterized for enrichment in markers
of specific synapse, cell and disease types, using the same
method described above. Moreover, to evaluate the biological
and functional relevance of ASD-associated modules we used
the Enrichr web tool. We analyzed the overrepresentation of
the biological processes GO category for each gene list of
modules.
Gene Lists Used for Enrichment Analyses
SFARI database (https://gene.sfari.org/autdb/Welcome.do) was
used to calculate enrichment with ASD-associated genes on
BTBR and En2−/− hippocampal DEGs. For disease annotations,
we used the following gene sets from Autworks database
(http://autworks.hms.harvard.edu): epilepsy, parkinsonian
disorders and schizophrenia. For searching the recurrence
and overlaps with FMRP-associated genes, we used a set of
842 genes (herein termed “FMRP Interacting Genes”), from
a crosslinking and immunoprecipitation (CLIP) experiment
(Darnell et al., 2011). Other gene lists used in this study (neuronal
markers, astrocyte markers, type 1 microglial markers, type 2
microglial markers, oligodendrocyte markers, postsynaptic
density, asdM12, asdM16) are available at http://www.arkinglab.
org/resources. GABAergic synapse, glutamatergic synapse,
dopaminergic synapse lists were taken from http://www.genome.
jp/kegg/. In addition, the following gene lists were compiled
from MsigDB (http://www.broadinstitute.org/gsea/msigdb/
collections.jsp#C1): GABAergic presynaptic markers (GABA
synthesis, release, reuptake and degradation); GABAergic
postsynaptic markers (GABA A receptor activation, GABA B
receptor activation, GABA receptor activation); glutamaergic
presynaptic markers (glutamate neurotransmitter release cycle);
glutamaergic postsynaptic markers (glutamate receptor activity;
glutamate signaling pathway); dopaminergic markers (dopamine
neurotransmitter release cycle).
RESULTS
Recently, we showed by transcriptome analysis that several
genes related to ASD, abnormal synaptic transmission and
GABA signaling are markedly deregulated in the hippocampus
of En2−/− mice (Sgadò et al., 2013b). Here we extended this
analysis to the hippocampus of BTBRmice, to test the hypothesis
that common and distinct downstream mechanisms may be
altered in these two ASD mouse models. Hippocampi from
BTBR and B6 control adult mice were assessed for differential
gene expression by microarray and bioinformatic analysis, as
previously reported for En2−/− mice (Sgadò et al., 2013b). We
found 1016 differentially expressed genes in the hippocampus
of BTBR mice compared to their B6 controls (Figure 1A).
Among these, 436 and 580 were up- and down-regulated,
respectively. Supplementary Table 2 shows the entire list of
genes differentially expressed in the BTBR hippocampus, with
fold change, percentage of false prediction (pfp) and P-values
calculated by RankProd. We next validated microarray findings
by qRT-PCR analysis, selecting seven representative genes from
the DEGs list. Except for Gabra5, for which decreased protein
and mRNA levels were found in the brains of ASD patients
(Fatemi et al., 2010), many of the selected genes belong to
immune/inflammatory categories. All genes showed statistically
significant differential expression in the BTBR hippocampus,
as compared to B6 controls [chemokine (C-C motif) ligand
21A (Ccl21a) p = 0.0424; gamma-aminobutyric acid (GABA)
A receptor, subunit alpha 5 (Gabra5) p = 0.0069; glial fibrillary
acidic protein (Gfap) p = 0.009; polymerase (RNA) E (DNA
directed) polypeptide E (Polr3e) p = 0.025; cyclin-dependent
kinase inhibitor 1A (P21) (Cdkn1a) p = 0.0052; protein kinase
C, delta polypeptide E (Polr3e) p = 0.0029; SLIT and NTRK-
like family, member 6 (Slitrk6) p = 0.0018] (Figure 1B). In
all tested genes the expression difference reported by qRT-PCR
significantly correlated with microarray data (Pearson r = 0.97,
p < 0.0003).
We next compared the BTBR hippocampal transcriptional
profile to that of En2−/− mice. We first identified a total number
of 153 commonly expressed genes between BTBR and En2−/−
mice Interestingly, some of the common DEGs are related to
inflammatory pathways (Aldh1a2, C2, Ccnd1, Cox7b2, Eif2ak2,
Gsk3a, H2-Aa, H2-A1, H2-Bl, Map3k6, Pglyrp1, Slpi, Tia1;
Figure 2A). qRT-PCR confirmed the differential expression of
two of these genes [cyclin D1 (Ccdn1), p = 0.0018 and p =
0.0051 for BTBR and En2−/− mice, respectively; peptidoglycan
recognition protein 1 (Pglyrp1), p = 0.0052 and p = 0.0284 for
BTBR and En2−/− mice, respectively] (Figure 2B).
We next explored whether shared functional categories or
common pathways were perturbed in both ASD mouse models.
To increase accuracy of the functional analysis, we decided
to compare the two lists of DEGs using updated databases
and different bioinformatic tools, respect to those previously
employed for the analysis of the hippocampal trascriptome
of En2−/− mice (Sgadò et al., 2013b). We tested BTBR
and En2−/− hippocampal DEGs for enrichment of mouse
phenotype terms (Mouse Genome Informatics Mammalian
Phenotype Level 4) using Enrichr (Figure 3). Two significantly
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FIGURE 1 | Differentially expressed genes in the BTBR hippocampus.
(A) Schematic representation of BTBR hippocampal DEGs, as compared to
control B6 mice. A total of 1016 DEGs were identified, (580 down-regulated,
436 up-regulated). (B) qRT-PCR validation of differentially expressed genes.
qRT-PCR results for all the evaluated genes were in agreement with microarray
results. Values are expressed as each gene/L41 comparative quantitation
ratios normalized on the expression of WT (mean ± s.e.m of three replicates
from pools of six animals per genotype; p < 0.05, Student’s t-test, BTBR vs.
B6).
enriched phenotypes were common to both mouse strains:
abnormal behavioral responses and abnormal eating/drinking
behavior. Conversely, specific phenotype ontologies enriched in
BTBR were abnormal sensory capabilities, neurodegeneration,
abnormal innate immunity and abnormal antigen presenting
(Figure 3A). For En2−/− mice, we confirmed a significant
enrichment for terms related to seizure and altered synaptic
transmission (Figure 3B), as previously reported (Sgadò et al.,
2013b). KEGG pathways analysis for BTBR and En2−/−
hippocampal DEGs was performed with DAVID, using tissue-
specific lists of expressed genes as background for each ASD
mouse model (see Materials and Methods). The common
pathways that were most significantly enriched across the
differentially expressed genes of both ASD mouse models were
related to chemokine signaling, MAPK signaling, systemic lupus
erythematosus, Fc gamma receptor mediated phagocytosis and
pathways in cancer (Figure 4).
To further reveal similarities and differences between the
BTBR and En2−/− hippocampal transcriptome, we tested
whether the two lists of DEGs were specifically enriched
for cell-type specific markers and genes implicated in
neurodevelopmental and neurodegenerative diseases (ASD,
FIGURE 2 | DEGs commonly expressed in the BTBR and En2−/−
hippocampus. (A) Venn diagram of differentially expressed genes in the
BTBR and En2−/− adult hippocampus. A total of 1016 and 862 differentially
expressed genes were identified in BTBR (brown) and En2−/− (gray) mice,
respectively. Among these, 153 show differential expression in both strains.
The table shows a subset of these common DEGs, all belonging to
inflammatory pathways. (B) qRT-PCR validation of Ccnd1 and Pglyrp1, two
genes differentially expressed in both BTBR and En2−/− hippocampi.
qRT-PCR results for both genes were in agreement with microarray results.
Values are expressed as each gene/L41 comparative quantitation ratios
normalized on the expression of respective control (mean ± s.e.m of three
replicates from pools of six animals per genotype; p < 0.05, Student’s t-test,
BTBR vs. B6 and En2−/− vs. En2+/+).
SCZ, epilepsy, Parkinson’s). Remarkably, when compared to
these repositories, BTBR and En2−/− hippocampal DEGs
were enriched in SCZ- and ASD-related genes according
to SFARI 2014 dataset (Figure 5A), consistent with reports
showing overlap in candidate genes between ASD and SCZ
(Crespi et al., 2010). Furthermore, when we separately analyzed
up- and down-regulated genes, we found a significant over-
representation of neuronal markers for both BTBR and
En2−/− down-regulated DEGs; conversely, a significant
over-representation of astrocyte markers was found in BTBR
and En2−/− up-regulated DEGs (Figure 5A). Significant
differences were also detected between the two strains. Among
the genes down-regulated in the En2−/− hippocampus the
following terms were significantly enriched: epilepsy, asdM12
(a neuronal module enriched for ASD-associated genes;
Voineagu et al., 2011), FMR1 interacting genes, dopaminergic
markers, GABAergic postsynaptic markers and glutamatergic
presynaptic markers; conversely, type I microglia markers were
significantly enriched among BTBR down-regulated genes
(Figures 5A,B).
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FIGURE 3 | Overrepresented mouse phenotype categories for differentially expressed genes in BTBR and En2−/− hippocampi. BTBR and En2−/−
hippocampal DEGs were analyzed for enrichment in phenotype ontology categories using Enrichr, with an adjusted p < 0.05. For each category, the number of genes
is indicated by the length of the horizontal bars (gene counts). Dashed red lines highlight phenotype categories common to BTBR (A) and En2−/− (B) DEGs.
To further investigate the presence of common molecular
networks deregulated across autistic mice as compared to
their respective controls, we analyzed the entire gene expression
dataset (BTBR+En2−/− vs. B6+En2+/+) usingWGCNA (Zhang
and Horvath, 2005). This analysis allows to identify discrete gene
modules based on co-expression profiles (Voineagu et al., 2011).
WGCNA identified 18 main modules for groups of genes with
high topological overlap, ranging between 28 and 653 probes in
size (Supplementary Table 3). The modules were correlated to
the disease trait using a linear mixed regression framework and
then ranked based on their enrichment in term of genes present
in the SFARI list (retrieved on 2015). Six out of the eighteen
modules were significantly enriched in ASD-related genes
(Blue, p = 9.072043e-09; Brown, p = 6.297529e-08; Black, p =
7.691951e-06; Pink, p= 0.00021; Greenyellow, p= value 0.00054;
Red, p = 0.0044) (Figure 6A). We next tested the association of
each of the six ASD-enriched modules for enrichment analysis.
Except the Greenyellow module, all modules shared a significant
enrichment for neuronal markers, as well as for genes associated
to epilepsy and SCZ (Figure 6A). The Greenyellow module
was enriched only for FMRP-interacting and glutamatergic
synapse genes. Brown and Red modules were significantly
enriched for oligodendrocyte markers and genes associated with
M2-microglial cell states. For a better functional characterization
of ASD-associated modules, we also used Enrichr to assess the
GO biological process annotation of the six ASD gene-enriched
modules. Blue, Black, Pink, and Redmodules, which are enriched
for neuronal markers (Figure 6A) also contain genes with the
GO term “regulation of ion transmembrane transport” or
“synaptic transmission” (Figure 6B). The Brown module, one of
most enriched for categories (neuronal markers, type 2microglial
markers, oligodendrocyte markers, postsynaptic density, FMRP
interacting genes, GABAergic/glutamatergic/dopaminergic
synapse, epilepsy, schizophrenia; Figure 6A), showed an over-
representation of genes involved in cognition, learning, and
memory. Finally, the Greenyellow module did not show any
significant over-representation of GO categories (Figure 6B).
DISCUSSION
Brief Summary of Results
In this study, we compared the hippocampal transcriptome of
BTBR and En2−/− adult mice, two robust animal models of
ASD. We identified both common and distinct gene pathways
represented in the BTBR and En2−/− transcriptome. Common
pathways included chemokine and MAP kinase signaling,
whereas genes involved in immune dysfunction and abnormal
synaptic transmission were specifically represented among BTBR
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FIGURE 4 | Overrepresented pathways categories for differentially expressed genes in BTBR and En2−/− hippocampi. BTBR and En2−/− hippocampal
DEGs were analyzed for enrichment in KEGG pathways categories using DAVID, with an adjusted p < 0.05. For each category, the number of genes is indicated by
the length of horizontal bars (gene counts). Dashed red lines highlight pathways common to BTBR (A) and En2−/− (B) DEGs.
and En2−/− DEGs, respectively. Both BTBR and En2−/−
hippocampal DEGs showed a significant enrichment of ASD
and SCZ-associated genes, with specific gene sets enriched in
the two models (glial genes in BTBR; GABAergic, glutamatergic
FMRP-related and epilepsy-related genes in En2−/−). Finally,
network analysis (WGCNA) performed on BTBR and En2−/−
hippocampal DEGs together identified six modules significantly
enriched in ASD-associated genes, with specific enrichment
profile in neuronal, glial, epilepsy-related, and SCZ-associated
genes.
Common Pathways Deregulated in the
BTBR and En2−/− Hippocampus
Our comparative microarray analysis revealed that 155 genes
(out of a total of 44,000) are differentially expressed in both
BTBR and En2−/− hippocampus (Figure 1), indicating that a
very low of number of genes (0.35%) are commonly deregulated
among these two ASD mouse models. Nevertheless, ontology
analyses for phenotypes and cellular pathways revealed that
some common gene categories are significantly over-represented
among the genes differentially expressed in the BTBR and
En2−/− hippocampus, as compared to their respective controls
(B6, En2+/+ mice). Mammalian Phenotype ontology revealed
that genes involved in abnormal behavioral responses are
significantly deregulated in both mouse models (Figure 2).
Most importantly, KEGG pathways analysis showed that genes
related to immune response and inflammation are significantly
deregulated in both BTBR and En2−/− hippocampus (KEGG
pathways: chemokine signaling, MAPK signaling, systemic lupus
erythematosus, Fc gamma receptor mediated phagocytosis;
Figure 3). This is in line with our current knowledge about
the role of the immune system in ASD pathogenesis. Genetic
studies indicate that several genes encoding components of the
immune system are associated to ASD. In addition, data from
both ASD individuals and animal models indicate a significant
dysregulation of immune processes in ASD, such as up-
regulation of pro-inflammatory cytokines/chemokines, increased
expression of major histocompatibility complex, and activation
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FIGURE 5 | Enrichment analysis on BTBR and En2−/− hippocampal DEGs. Lists of BTBR and En2−/− hippocampal DEGs (all, up-regulated and
down-regulated) were analyzed for enrichment in genes belonging to specific categories relevant to the autistic phenotype (A) and neuronal subtypes (B). Gene lists
were compiled from the literature (see Materials and Methods and references therein). Significance of enrichment is indicated (white, p > 0.05; gray, p < 0.05).
ofmicroglia in the brain (reviewed in Estes andMcAllister, 2015).
Significantly increased levels of pro-inflammatory cytokines (IL-
1β, IL-6) and microglia activation have been reported in BTBR
brains (Heo et al., 2011; Onore et al., 2013; Zhang et al., 2013),
similarly to what observed in post-mortem brain tissue fromASD
patients (Vargas et al., 2005; Li et al., 2009; Suzuki et al., 2013).
It is important to point out that, although the B6 strain
is commonly used to compare with BTBR in molecular and
behavioral studies (reviewed in Silverman et al., 2010), it exists
the possibility that it is not an ideal or sufficient control for
BTBR in gene expression studies. Indeed, linkage disequilibrium
studies showed that B6 and BTBR mice are on different branches
of the mouse genetic tree (Petkov et al., 2005). Thus, further
genetic characterization is needed to identify the ideal control
strain for inbred BTBR mice. In the absence of such a control,
we conformed to previous studies using B6 as a control for
BTBR in transcriptional profiling analyses (Daimon et al.,
2015).
Differently from what reported in this study, our previous
transcriptome profiling revealed a significant deregulation of
immune- and inflammation-related genes in the cerebellum but
not hippocampus of En2−/− adult mice (Sgadò et al., 2013b). One
possible explanation is that our previous gene ontology analysis
of the En2−/− hippocampal transcriptome was performed using
different databases than those used for the present study.
Preliminary unpublished data from our laboratory however
indicate that the expression of several immune mediators (IL-
1β, TNF-α, toll-like receptor 2, CCL2, CCL5) is significantly
deregulated in the hippocampus (as well as neocortex and
cerebellum) of En2−/− adult mice.
Our enrichment analyses revealed that both sets of BTBR
and En2−/− hippocampal DEGs are enriched in ASD-related
genes according to the SFARI 2014 dataset. En2−/− hippocampal
DEGs also showed a significant enrichment in genes contained
in two additional datasets of autism-related genes (asdM12
and SFARI15). This confirms that both BTBR and En2−/−
mice are valuable mouse models to investigate ASD-relevant
gene signatures. Most importantly, these enrichment analyses
showed that both BTBR and En2−/− DEGs dataset are
significantly enriched in SCZ-associated genes (Figure 5). This
is in agreement with recent results from large-scale genomic
studies showing that ASD and SCZ are neurodevelopmental
disorders characterized by overlapping genetics and phenotypes
(Murdoch and State, 2013). Genetic lesions at the origin of
these disorders are thought to affect brain circuit formation
and synaptic function during embryonic and/or postnatal
development, ultimately leading to a varying range of (partially
overlapping) pathological behaviors in ASD and SCZ. Recent
genomic studies show that control subjects carrying copy-
number variants (CNVs) conferring risk of ASD or SCZ
poorly perform in cognitive tests (Stefansson et al., 2014),
suggesting that conserved genetic mechanisms might underlie
shared co-morbidities in these two neurodevelopmental
disorders.
Enrichment analyses also showed that both sets of BTBR
and En2−/− hippocampal DEGs are enriched in neuronal
and astrocyte markers. The importance of glial cells in ASD
pathophysiology was initially suggested by RNA sequencing
studies showing a significant enrichment of glial genes belonging
to immune/inflammatory categories in ASD brain tissues
(Voineagu et al., 2011). These gene expression results are
supported by neuroanatomical data showing glial cell activation
in ASD postmortem brains (reviewed in Petrelli et al.,
2016).
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FIGURE 6 | Enrichment and gene ontology analyses on co-expression modules resulting from WGCNA on BTBR and En2−/− hippocampal DEGs. (A)
Co-expression modules enriched in SFARI genes were analyzed for enrichment in genes belonging to specific categories relevant to the autistic phenotype, as
indicated. Gene lists were as in Figure 5. Significance of enrichment is indicated (white, p > 0.05; gray, p < 0.05). (B) Co-expression modules were analyzed for
enrichment in GO categories using Enrichr, with an adjusted p < 0.05. For each category, the number of genes is indicated by the length of horizontal bars (gene
counts). Modules are indicated in their respective colors. The Greenyellow module is not indicated in the graph since it did not show any significant
over-representation of GO terms.
Distinct Pathways Deregulated in the
BTBR and En2−/− Hippocampus
Phenotype and gene ontology analyses, along with enrichment
analyses, also confirmed that marked differences are present
between the hippocampal gene expression profiles of BTBR
and En2−/− adult mice. Mammalian Phenotype ontology
analysis showed that the “abnormal innate immunity” and
“seizure/abnormal synaptic transmission” pathways are
significantly over-represented among hippocampal DEGs
in BTBR and En2−/− adult mice, respectively (Figure 2).
Abnormal immune response has been clearly demonstrated in
BTBR mice (see Careaga et al., 2015, and references above).
As an example, when pregnant dams of BTBR and C57BL/6J
inbred strains were exposed to the viral mimic polyinosinic-
polycytidylic acid (polyI:C), severe ASD-like behaviors and
persistent dysregulation of adaptive immune system function
were only observed in BTBR offspring (Schwartzer et al.,
2013).
The gene expression signature of the BTBR hippocampus
resulting from the present study is markedly different from that
previously published by other authors. We detected a total of
1016 BTBR DEGs, whereas the number of BTBR DEGs detected
by Daimon et al. (2015) was significantly lower (301). Only
69 BTBR DEGs were common to the two datasets. In both
studies, the hippocampal BTBR transcriptome was compared to
that of C57BL/6J inbred mice, and adult mice of comparable
age were used (5 months in our study, 4 months in Daimon
et al., 2015). However, Daimon et al. (2015) used a different
microarray platform (Illumina), microarray analysis software
(DIANE 6.0) and pathways analysis software (WebGestalt, http://
bioinfo.vanderbilt.edu/), which can justify the difference in the
obtained results.
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As for the specific gene expression signature of the En2−/−
hippocampus, KEGG pathway analysis performed in the present
study confirmed our previous analysis (Sgadò et al., 2013b).
Indeed, a marked excitation/inhibition unbalance is present in
the En2−/− hippocampus and neocortex, as suggested by the
increased seizure susceptibility (Tripathi et al., 2009) and loss
of GABAergic interneurons (Sgadò et al., 2013a; Allegra et al.,
2014; Provenzano et al., 2014) observed in En2−/− mice. These
data are also supported by this study (Figure 5), which reveals a
significant enrichment of GABAergic/glutamatergic postsynaptic
markers among the genes down-regulated in the En2−/−
hippocampus; genes interacting with fragile Xmental retardation
protein (FMRP) are also enriched, in keeping with the marked
down-regulation of the FMRP pathway detected in the En2−/−
hippocampus (Provenzano et al., 2015). Finally, dopaminergic
markers are also enriched among the genes down-regulated in
the En2−/− hippocampus, in keeping with the established role of
Engrailed proteins in regulating the development and function of
dopaminergic neurons (Gherbassi and Simon, 2006). Conversely,
microglia markers are significantly enriched among genes down-
regulated in the BTBR hippocampus, thus confirming the
marked dysregulation of glial cell function in this ASD model.
Accordingly, histopathological studies revealed glial cells but not
GABAergic neurons alterations in the hippocampus of BTBR
mice (Stephenson et al., 2011).
Weighted Correlation Network Analysis
Reveals ASD-Relevant Gene Expression
Modules
Based on the significant similarities detected between the BTBR
and En2−/− hippocampal DEGs (Figures 2, 3), we considered
the gene expression signature of these two ASD mouse models
together, and compared it to that of their respective control
strains (C57Bl/6J and En2+/+). We then performed weighted
gene co-expression network analysis (WGCNA; Langfelder and
Horvath, 2008) to identify correlation patterns among genes
across the ASD models vs. control microarray samples, and find
gene clusters (modules) whose expression is highly correlated.
Genes differentially expressed in ASD mouse models were
clustered in 18 modules, and our WGCNA showed that 6 out
of these 18 modules were significantly enriched in ASD-related
genes. Each of these 6 ASD genes-enriched modules showed
a specific enrichment profile in neuronal and glial genes, as
well as in genes associated to epilepsy and SCZ. This is in
line with WGCNA performed on gene signatures from ASD
post-mortem cortical brain tissue, which showed a significant
deregulation of glial and neuronal activity-dependent genes in
autism (Gupta et al., 2014). It is also important to note that
ASD and epilepsy show a high degree of comorbidity (Buckley
and Holmes, 2016), and conserved genetic mechanisms have
been proposed to underlie ASD and SCZ (see above in this
discussion; Stefansson et al., 2014). Thus,WGCNA performed on
microarray samples from autistic vs. control mouse strains is able
to identify conserved gene expression signatures across different
ASD mouse models.
CONCLUSIONS
The present study reveals significant transcriptional similarities
and differences between the BTBR and En2−/− hippocampus,
confirming the idea that transcriptome profiling of specific brain
areas from ASD mouse models may contribute to identify novel
molecular targets for pharmacological studies.
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